2025-05-27 - Analysis Report
Okay, here's an analysis of Natera Inc. (NTRA), incorporating all the provided data points.

**1. Performance vs. S&P 500 (VOO):**

*   **Ticker:** NTRA
*   **Company Description:** Natera Inc. is a genetic testing company focused on non-invasive prenatal testing (NIPT) and other genetic screening products.
*   **NTRA Cumulative Return:** 126.76%
*   **VOO Cumulative Return:** 79.81%
*   **Absolute Spread:** 46.9%
*   **Relative Spread:** 13.5 (Indicates NTRA's outperformance is in the 13.5th percentile of its historical range relative to VOO)

**Analysis:** NTRA has significantly outperformed the S&P 500 (VOO) over the period considered. However, the relative spread suggests that the current outperformance isn't historically extreme.

Here's a table summarizing the Alpha, Beta, and other metrics:

| Year       | CAGR    | MDD     | Alpha    | Beta | Cap (B) |
|------------|---------|---------|----------|------|---------|
| 2015-2017  | -6.0%   | 62.4%   | -31.0%   | -0.0 | 1.2     |
| 2016-2018  | 29.0%   | 80.1%   | 11.0%    | 0.1  | 1.9     |
| 2017-2019  | 159.0%  | 80.1%   | 130.0%   | 1.2  | 4.6     |
| 2018-2020  | 530.0%  | 80.1%   | 505.0%   | 0.6  | 13.6    |
| 2019-2021  | 356.0%  | 62.9%   | 301.0%   | 0.2  | 12.8    |
| 2020-2022  | -119.0% | 62.9%   | -125.0%  | 0.3  | 5.5     |
| 2021-2023  | -482.0% | 69.9%   | -499.0%  | 1.2  | 8.6     |
| 2022-2024  | -75.0%  | 70.5%   | -92.0%   | 1.3  | 21.6    |
| 2023-2025  | 75.0%   | 72.8%   | 48.0%    | 0.9  | 20.9    |

**Analysis:**

*   **CAGR:** Fluctuates widely, indicating periods of significant growth and decline.
*   **MDD:** Consistently high Maximum Drawdown (MDD) values indicate significant volatility and potential for large losses.
*   **Alpha:** The Alpha values mirror the CAGR trends, highlighting periods of substantial outperformance and underperformance relative to the benchmark.
*   **Beta:** Beta values vary, suggesting the stock's sensitivity to market movements changes over time.  Higher Beta values (e.g., 1.2, 1.3) indicate greater volatility than the market.
*   **Cap(B):** The company's market capitalization has varied over the years, reflecting the stock's price fluctuations.

**2. Recent Price Action:**

*   **Current Price:** $153.32
*   **Previous Close:** $152.48
*   **Change:** 0.55
*   **5-day Moving Average:** $152.94
*   **20-day Moving Average:** $154.10
*   **60-day Moving Average:** $148.54

**Analysis:** The price has recently increased slightly. The 5-day moving average is below the 20-day moving average, which is a short-term bearish signal. However, the 60-day moving average is below the current price, which is a longer-term bullish signal.

**3. Technical Indicators:**

*   **Market Risk Indicator (MRI):** 0.366 (Low Risk)
*   **RSI:** 45.34 (Neutral)
*   **PPO:** -0.2985 (Neutral)
*   **Hybrid Signal:** Cash_70%_Sell 0.2% of holdings (1 shares - Caution - MRI:0.37)
*   **Recent (20-day) Relative Spread Change:** 0.7 (Positive - short-term increase)
*   **Expected Return:** 125.8% (Long-term, relative to S&P 500)

**Analysis:** The MRI indicates low market risk. The RSI is neutral, suggesting neither overbought nor oversold conditions. The PPO is slightly negative, indicating some recent weakness. The hybrid signal suggests a cautious approach with a high cash allocation. The positive change in relative spread suggests short-term improvement. The extremely high expected return should be treated with caution, as it's a projection and could be influenced by various factors.
The change from the previous close is $0.55, indicating a moderate uptick, but not a significant " 급반등 " or " 급하락."

**4. Recent News & Significant Events:**

*   **[2025-05-24]:** Major business developments, regulatory changes, or market events.
*   **[2025-05-23]:** Analysts discussing performance and outlook.
*   **[2025-05-26]:** Notable stock volatility.
*   **[2025-05-25]:** Market experts highlighting risks and opportunities.

**Analysis:** Recent news suggests increased activity and volatility surrounding NTRA, with analysts actively discussing its performance and outlook. Investors should closely monitor news and company announcements.

**5. Recent Earnings Analysis:**

| 날짜       | EPS   | 매출      |
|------------|-------|-----------|
| 2025-05-09 | -0.5  | 0.50 B$   |
| 2024-11-12 | -0.26 | 0.44 B$   |
| 2024-08-09 | -0.3  | 0.41 B$   |
| 2024-05-10 | -0.56 | 0.37 B$   |
| 2025-05-09 | -0.56 | 0.37 B$   |

**Analysis:**

*   The company consistently reports negative Earnings Per Share (EPS), indicating a lack of profitability.
*   Revenue has generally been increasing over the past few quarters, which is a positive sign, but the company is still not profitable. Note: There is a duplicated entry for 2025-05-09 with conflicting revenue figures, which should be verified.

**6. Financial Information:**

**Revenue and Profitability:**

| Quarter    | Revenue | Profit Margin |
|------------|---------|---------------|
| 2025-03-31 | $0.50B  | 63.12%        |
| 2024-12-31 | $0.48B  | 62.94%        |
| 2024-09-30 | $0.44B  | 61.79%        |
| 2024-06-30 | $0.41B  | 58.83%        |
| 2024-03-31 | $0.37B  | 56.72%        |

**Capital and Profitability:**

| Quarter    | Equity    | ROE       |
|------------|-----------|-----------|
| 2025-03-31 | $1.24B    | -5.40%    |
| 2024-12-31 | $1.20B    | -4.50%    |
| 2024-09-30 | $0.88B    | -3.60%    |
| 2024-06-30 | $0.84B    | -4.48%    |
| 2024-03-31 | $0.79B    | -8.51%    |

**Analysis:**

*   **Revenue:** Consistent growth in revenue over the past five quarters.
*   **Profit Margin:** Consistently high and increasing profit margins suggest good cost control.
*   **Equity:**  Equity has increased, suggesting a strengthening balance sheet.
*   **ROE:** Negative Return on Equity (ROE) indicates that the company is not generating profits from its equity. The negative ROE needs to be addressed.

**7. Overall Summary:**

NTRA presents a mixed picture.

*   **Positives:** Significant historical outperformance against the S&P 500, recent revenue growth, strong profit margins, increasing equity, and a potentially very high long-term expected return (though to be treated with caution).
*   **Negatives:** High historical volatility (MDD), consistent negative EPS (lack of profitability), negative ROE, and a Hybrid Signal suggesting a cautious investment approach.

**Conclusion:**

NTRA is a high-growth, high-risk stock. While it has demonstrated the potential for significant outperformance, it also carries substantial volatility and hasn't yet achieved consistent profitability. The recent news suggests increased market attention and potential volatility. Investors should carefully weigh their risk tolerance and conduct thorough due diligence before investing in NTRA.  The very high expected return is a speculative projection, and the negative ROE is a serious concern that the company needs to address. Monitor upcoming earnings reports and company announcements closely.
